BioLine RX Ltd (NASDAQ:BLRX)
| 2.06 Delayed Data As of Feb 14 |  +0.0248 / +1.22%Today’s Change | 1.55 Today|||52-Week Range 7.46 | -8.23% Year-to-Date |
Latest BLRX News | Press Releases
No recent news for BioLine RX Ltd.
Today’s Trading
| Previous close | 2.04 |
| Today’s open | 2.03 |
| Day’s range | 2.02 - 2.12 |
| Volume | 27,153 |
| Average volume (3 months) | 153,481 |
| Market cap | $24.4M |
Data as of 3:59pm ET, 02/14/2020
Growth & Valuation
| Earnings growth (last year) | +22.49% |
| Earnings growth (this year) | +26.41% |
| Earnings growth (next 5 years) | -25.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SXTCChina SXT Pharmaceut... | -0.02 | -2.46% |
| SPHSSophiris Bio Inc | +0.01 | +1.80% |
| ZSANZosano Pharma Corp | +0.22 | +38.55% |
| KZIAKazia Therapeutics L... | -0.16 | -3.87% |
Data as of 4:00pm ET, 02/14/2020
Financials
| Next reporting date | March 18, 2020 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$22.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Modi'in, Tel Aviv |
Forecasts
